Section 1: Introduction to Antimicrobial Stewardship (Self Study for medical students)

Congratulations!

You now have access to the 2019 Core Antimicrobial Stewardship (CAS) Curriculum Self Study. 

Start by reviewing the Self Study User Guide to get familiar with background information and concepts that will be presented during this course. 

Next,  download the following resources below.

  • Self Study Roadmap/User Guide - full resource manual that explains the overall curriculum, learning objectives, and navigating the LMS
  • Curriculum Planner - one page document that allows you to build a timeline for completing all sections and modules
  • AS Clinical Teaching Tool - front/back document used to apply and reinforce AS principles into everyday clinical practice
  • AS Core Concepts - one page document that covers the 5 Core Concepts for the Curriculum

Be sure to complete the Self Study Pre and Post Curriculum Survey. They are required in order to receive CME/MOC credit and your certificate.

Target Audience

Infectious Diseases Professionals who desire to learn more about antimicrobial stewardship but are not in a participating fellowship program, no longer in fellowship, or would like to gain more knowledge on the subject.

Learning Objectives

Upon completion of Section 1, you should be able to:

  • Define antimicrobial stewardship, its programmatic goals, and key strategies to achieve the goals
  • Relate trends and patterns between antimicrobial use and resistance
  • Recognize adverse events associated with the use of specific antimicrobials, including the risk for development of C. difficile infections
  • Describe the role of clinical and laboratory diagnostic tools in improving antimicrobial use
  • Define expected outcomes of an ASP

NOTE: Because this curriculum was initially designed specifically for fellows, you may hear repeated reference to "fellows" ,"stewards in training" or "fellows/trainees"

Course summary
Course opens: 
04/04/2020
Course expires: 
04/01/2021

AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found

NameIndividual's Role in ActivityName of Commercial InterestNature of Relationship
Abbo, LillianWorkgroup memberPfizer BrazilHonoraria
Advani, SonaliWorkgroup memberNabriva TherapeuticsAdvisory/Consultant Role
Amstrong, WendyWorkgroup memberNone 
Barsoumian, AliceWorkgroup memberNone 
Beeler, ColeWorkgroup memberNone 
Bystritsky, RachelWorkgroup memberNone 
Cherabuddi, KartikWorkgroup memberGatoradeStart - up Research Fund
  NIH (Medimmune)Research Grant
Cohen, SethWorkgroup memberNone 
Hamilton, KeithWorkgroup memberNone 
Ince, DilekWorkgroup memberAnsun PharmaResearch Grant
Justo, Julie AnnWorkgroup memberNone 
Logan, AshleighStaffNone 
Luther, VeraWorkgroup memberNone 
Lynch, JohnWorkgroup memberAstellas Pharmaceuticals, Juno TherapeuticsAdvisory/Consultant Role
Nori, PriyaWorkgroup memberNone 
Ohl, ChristopherWorkgroup memberParatek, Bayer, Cempra PharmaceuticalsAdvisory/Consultant Role
Patel, PayalWorkgroup memberNone 
Pottinger, PaulWorkgroup memberMcGraw Hill, ElsevierHonoraria
Schwartz, BrianWorkgroup memberNone 
Spicer, JenniferWorkgroup memberNone 
Stack, ConorWorkgroup memberNone 
Zhou, YuanWorkgroup memberNone 
Shnekendorf, RachelStaffNone 
Please login or register to take this course.

Required Hardware/software

PCs Running Window

  • Windows 10  
  • Microsoft Edge
  • Firefox
  • Google Chrome

Apple Computers Running OSX

  • Safari
  • Firefox
  • Google Chrome